25 XP 0   0   10  
0coffee
Main menu
3rd party ad coffee SUPPORTERis ad-free.

SCYX (Scynexis) Stock Analysis
Buy, Hold or Sell?

Let's analyze Scynexis together

I guess you are interested in Scynexis Inc. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

  • πŸ“Š Fundamental Analysis (FA) – Scynexis’s Financial Insights
  • πŸ“ˆ Technical Analysis (TA) – Scynexis’s Price Targets

I'm going to help you getting a better view of Scynexis Inc. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

Get notifications about Scynexis Inc

I send you an email if I find something interesting about Scynexis Inc.

1. Quick Overview

1.1. Quick analysis of Scynexis (30 sec.)










1.2. What can you expect buying and holding a share of Scynexis? (30 sec.)

How much money do you get?

How much money do you get?
$0.00
When do you have the money?
1 year
How often do you get paid?
5.0%

What is your share worth?

Current worth
$0.89
Expected worth in 1 year
$0.54
How sure are you?
42.5%

+ What do you gain per year?

Total Gains per Share
$-0.35
Return On Investment
-31.9%

For what price can you sell your share?

Current Price per Share
$1.10
Expected price per share
$1.06 - $1.41
How sure are you?
50%
3rd party ad coffee SUPPORTERis ad-free.

2. Detailed Analysis

2.1. Valuation of Scynexis (5 min.)




Live pricePrice per Share (EOD)
$1.10
Intrinsic Value Per Share
$-4.60 - $13.75
Total Value Per Share
$-3.71 - $14.65

2.2. Growth of Scynexis (5 min.)




Is Scynexis growing?

Current yearPrevious yearGrowGrow %
How rich?$44.4m$74.8m-$22.7m-43.6%

How much money is Scynexis making?

Current yearPrevious yearGrowGrow %
Making money-$4.8m-$8.8m$3.9m81.3%
Net Profit Margin-870.4%-593.0%--

How much money comes from the company's main activities?

2.3. Financial Health of Scynexis (5 min.)




3rd party ad coffee SUPPORTERis ad-free.

3. Summary and Key Metrics

3.1. What can you expect buying and holding a share of Scynexis?

Welcome investor! Scynexis's management wants to use your money to grow the business. In return you get a share of Scynexis.

First you should know what it really means to hold a share of Scynexis. And how you can make/lose money.

Speculation

The Price per Share of Scynexis is $1.1. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Scynexis.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Scynexis, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is $0.89. Based on the TTM, the Book Value Change Per Share is $-0.09 per quarter. Based on the YOY, the Book Value Change Per Share is $-0.15 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is $0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Scynexis.

How much money are you going to get?

 MRQTTMYOY3Y5Y10Y
 $% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share$% of Price per Share
Usd Eps-0.14-12.6%-0.10-9.3%-0.18-16.7%0.2421.9%0.000.0%-0.09-8.2%
Usd Book Value Change Per Share-0.13-11.7%-0.09-8.0%-0.15-14.1%-0.01-1.2%0.043.4%-0.01-1.0%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.13-11.7%-0.09-8.0%-0.15-14.1%-0.01-1.2%0.043.4%-0.01-1.0%
Usd Price Per Share0.68-1.08-2.00-1.85-3.34-2.84-
Price to Earnings Ratio-1.22--3.18-6.21-0.88--3.21--2.33-
Price-to-Total Gains Ratio-5.26--8.39-115.29-34.63-35.37-5.58-
Price to Book Ratio0.76-0.96-1.31-2.73-5.33-4.66-
Price-to-Total Gains Ratio-5.26--8.39-115.29-34.63-35.37-5.58-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share1.1
Number of shares909
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.090.04
Usd Total Gains Per Share-0.090.04
Gains per Quarter (909 shares)-79.8533.80
Gains per Year (909 shares)-319.38135.22
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-319-3290135125
20-639-6480270260
30-958-9671405395
40-1278-12861540530
50-1597-16051675665
60-1916-19241810800
70-2236-22431945935
80-2555-2562110801070
90-2874-2881212151205
100-3194-3200213501340

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%3.09.00.025.0%4.016.00.020.0%6.034.00.015.0%7.043.01.013.7%
Book Value Change Per Share1.03.00.025.0%4.08.00.033.3%11.09.00.055.0%17.023.00.042.5%20.028.03.039.2%
Dividend per Share0.00.04.00.0%0.00.012.00.0%2.00.018.010.0%2.00.038.05.0%2.00.049.03.9%
Total Gains per Share1.03.00.025.0%4.08.00.033.3%11.09.00.055.0%17.023.00.042.5%20.028.03.039.2%
3rd party ad coffee SUPPORTERis ad-free.

3.2. Key Performance Indicators

The key performance indicators of Scynexis Inc compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-3Y+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.128-0.088-32%-0.155+21%-0.013-90%0.037-446%-0.012-91%
Book Value Per Share--0.8941.108-19%1.554-42%1.027-13%0.917-3%0.774+15%
Current Ratio--5.2014.289+21%5.348-3%5.051+3%5.474-5%6.787-23%
Debt To Asset Ratio--0.2670.331-19%0.406-34%0.549-51%0.610-56%0.552-52%
Debt To Equity Ratio--0.3650.512-29%0.689-47%3.096-88%2.839-87%2.282-84%
Dividend Per Share----0%-0%-0%0.000-100%0.000-100%
Enterprise Value--62138520.32576913510.361-19%124349210.138-50%103609629.112-40%163735078.193-62%142237366.675-56%
Eps---0.138-0.103-26%-0.184+33%0.241-158%0.000-100%-0.090-35%
Ev To Ebitda Ratio---1.625-3.113+92%-10.457+544%-4.737+192%-4.041+149%-4.221+160%
Ev To Sales Ratio--11.38934.247-67%21.681-47%22.756-50%35.760-68%287.401-96%
Free Cash Flow Per Share---0.151-0.131-13%-0.052-65%-0.055-64%-0.171+14%-0.178+18%
Free Cash Flow To Equity Per Share---0.151-0.203+34%-0.053-65%-0.043-71%0.070-316%0.022-787%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.011-1%1.006-1%
Intrinsic Value_10Y_max--13.753----------
Intrinsic Value_10Y_min---4.600----------
Intrinsic Value_1Y_max--0.013----------
Intrinsic Value_1Y_min---0.675----------
Intrinsic Value_3Y_max--1.079----------
Intrinsic Value_3Y_min---1.855----------
Intrinsic Value_5Y_max--3.400----------
Intrinsic Value_5Y_min---2.836----------
Market Cap46117390.000+27%33580520.32550954760.361-34%96118710.138-65%88187629.112-62%146384878.193-77%122473691.675-73%
Net Profit Margin---5.048-8.704+72%-5.930+17%-10.335+105%-9.629+91%-50.361+898%
Operating Margin----18.4350%-5.8500%-12.5790%-10.9000%-54.8570%
Operating Ratio--8.01017.098-53%8.297-3%11.908-33%13.410-40%89.628-91%
Pb Ratio1.231+39%0.7550.961-21%1.305-42%2.726-72%5.331-86%4.659-84%
Pe Ratio-1.987-63%-1.219-3.178+161%6.212-120%0.879-239%-3.210+163%-2.329+91%
Price Per Share1.100+39%0.6751.082-38%1.995-66%1.851-64%3.337-80%2.844-76%
Price To Free Cash Flow Ratio-1.825-63%-1.1204.924-123%-1.986+77%0.698-261%-5.194+364%-4.471+299%
Price To Total Gains Ratio-8.570-63%-5.259-8.387+59%115.293-105%34.632-115%35.371-115%5.579-194%
Quick Ratio--8.1526.705+22%7.131+14%6.816+20%6.442+27%9.005-9%
Return On Assets---0.113-0.068-40%-0.074-35%-0.067-41%-0.081-28%-0.118+4%
Return On Equity---0.155-0.097-37%-0.130-16%-0.640+313%-0.537+247%-0.516+233%
Total Gains Per Share---0.128-0.088-32%-0.155+21%-0.013-90%0.037-445%-0.011-91%
Usd Book Value--44467000.00052151250.000-15%74866000.000-41%49306250.000-10%42275700.000+5%34356725.000+29%
Usd Book Value Change Per Share---0.128-0.088-32%-0.155+21%-0.013-90%0.037-446%-0.012-91%
Usd Book Value Per Share--0.8941.108-19%1.554-42%1.027-13%0.917-3%0.774+15%
Usd Dividend Per Share----0%-0%-0%0.000-100%0.000-100%
Usd Enterprise Value--62138520.32576913510.361-19%124349210.138-50%103609629.112-40%163735078.193-62%142237366.675-56%
Usd Eps---0.138-0.103-26%-0.184+33%0.241-158%0.000-100%-0.090-35%
Usd Free Cash Flow---7495000.000-6025500.000-20%-2545750.000-66%-2009583.333-73%-7043300.000-6%-7412900.000-1%
Usd Free Cash Flow Per Share---0.151-0.131-13%-0.052-65%-0.055-64%-0.171+14%-0.178+18%
Usd Free Cash Flow To Equity Per Share---0.151-0.203+34%-0.053-65%-0.043-71%0.070-316%0.022-787%
Usd Market Cap46117390.000+27%33580520.32550954760.361-34%96118710.138-65%88187629.112-62%146384878.193-77%122473691.675-73%
Usd Price Per Share1.100+39%0.6751.082-38%1.995-66%1.851-64%3.337-80%2.844-76%
Usd Profit---6885000.000-4879250.000-29%-8847500.000+29%-1902500.000-72%-5814700.000-16%-6691100.000-3%
Usd Revenue--1364000.000814500.000+67%2416750.000-44%12382500.000-89%8188150.000-83%4119500.000-67%
Usd Total Gains Per Share---0.128-0.088-32%-0.155+21%-0.013-90%0.037-445%-0.011-91%
 EOD+5 -3MRQTTM+14 -22YOY+16 -203Y+12 -245Y+12 -2710Y+14 -25

3.3 Fundamental Score

Let's check the fundamental score of Scynexis Inc based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-1.987
Price to Book Ratio (EOD)Between0-11.231
Net Profit Margin (MRQ)Greater than0-5.048
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than18.152
Current Ratio (MRQ)Greater than15.201
Debt to Asset Ratio (MRQ)Less than10.267
Debt to Equity Ratio (MRQ)Less than10.365
Return on Equity (MRQ)Greater than0.15-0.155
Return on Assets (MRQ)Greater than0.05-0.113
Total4/10 (40.0%)

3.4 Technical Score

Let's check the technical score of Scynexis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.140
Total1/1 (100.0%)

4. In-depth Analysis

4.1 About Scynexis Inc

SCYNEXIS, Inc., a biotechnology company, develops medicines to overcome and prevent difficult-to-treat and drug-resistant infections in the United States. It offers BREXAFEMME for the treatment of patients with vulvovaginal candidiasis (VVC) and recurrent VVC. The company's lead product candidate is Ibrexafungerp, a drug for the treatment of invasive candidiasis and/or candidemia, refractory invasive fungal infections, invasive aspergillosis, VVC, and recurrent VVC. It also develops SCY-247 to treat systemic fungal diseases. The company has licensing and collaboration agreements with GlaxoSmithKline Intellectual Property (No. 3) Limited, Merck Sharp & Dohme Corp., Hansoh (Shanghai) Health Technology Co., Ltd., Jiangsu Hansoh Pharmaceutical Group Company Limited, CJSC (R-Pharm), and Cypralis Limited for the development, manufacture, and commercialization of ibrexafungerp. SCYNEXIS, Inc. was formerly known as SCYNEXIS Chemistry & Automation, Inc. and changed its name to SCYNEXIS, Inc. in June 2002. The company was incorporated in 1999 and is headquartered in Jersey City, New Jersey.

Fundamental data was last updated by Penke on 2025-09-05 07:49:04.

4.2 In-depth Summary

4.2.1. Financial Health Summary

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

4.2.2. Valuation Summary

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is cheap.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is cheap.
3rd party ad coffee SUPPORTERis ad-free.

4.3 Financial Health

4.3.1. Profitability

4.3.1 Profitability
4.3.1.1. Net Profit Margin

Measures how much net profitΒ Scynexis earns for each $1 of revenue.

  • Above 10% is considered healthy but always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Net Profit Margin of -504.8%Β means thatΒ $-5.05 for each $1Β in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Scynexis Inc:

  • The MRQ is -504.8%. The company is making a huge loss. -2
  • The TTM is -870.4%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-504.8%TTM-870.4%+365.6%
TTM-870.4%YOY-593.0%-277.4%
TTM-870.4%5Y-962.9%+92.5%
5Y-962.9%10Y-5,036.1%+4,073.2%
4.3.1.2. Return on Assets

Shows howΒ efficientΒ Scynexis is using its assets to generate profit.

  • Above 5% is considered healthyΒ but always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -11.3% Return on Assets means thatΒ Scynexis generatedΒ $-0.11 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Scynexis Inc:

  • The MRQ is -11.3%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -6.8%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-11.3%TTM-6.8%-4.6%
TTM-6.8%YOY-7.4%+0.6%
TTM-6.8%5Y-8.1%+1.4%
5Y-8.1%10Y-11.8%+3.7%
4.3.1.3. Return on Equity

Shows how efficient Scynexis is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • -15.5% Return on Equity means Scynexis generated $-0.15Β for eachΒ $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Scynexis Inc:

  • The MRQ is -15.5%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -9.7%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-15.5%TTM-9.7%-5.7%
TTM-9.7%YOY-13.0%+3.3%
TTM-9.7%5Y-53.7%+44.0%
5Y-53.7%10Y-51.6%-2.1%
3rd party ad coffee SUPPORTERis ad-free.

4.3.2. Operating Efficiency of Scynexis Inc.

4.3.2. Operating Efficiency
4.3.2.1. Operating Margin

MeasuresΒ how efficient Scynexis is operatingΒ .

  • Measures how much profit Scynexis makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • An Operating Margin of 0.0%Β means the company generated $0.00 Β for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Scynexis Inc:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-1,843.5%+1,843.5%
TTM-1,843.5%YOY-585.0%-1,258.5%
TTM-1,843.5%5Y-1,090.0%-753.5%
5Y-1,090.0%10Y-5,485.7%+4,395.7%
4.3.2.2. Operating Ratio

Measures how efficient Scynexis is keepingΒ operating costsΒ low.

  • Below 1 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • An Operation Ratio of 8.01 means that the operating costs are $8.01 for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Scynexis Inc:

  • The MRQ is 8.010. The company is inefficient in keeping operating costs low. -1
  • The TTM is 17.098. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ8.010TTM17.098-9.088
TTM17.098YOY8.297+8.801
TTM17.0985Y13.410+3.688
5Y13.41010Y89.628-76.218
3rd party ad coffee SUPPORTERis ad-free.

4.4.3. Liquidity of Scynexis Inc.

4.4.3. Liquidity
4.4.3.1. Current Ratio

Measures if Scynexis is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare toΒ Drug Manufacturers - Specialty & Generic industry mean).
  • A Current Ratio of 5.20Β means the company has $5.20 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Scynexis Inc:

  • The MRQ is 5.201. The company is very able to pay all its short-term debts. +2
  • The TTM is 4.289. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ5.201TTM4.289+0.912
TTM4.289YOY5.348-1.059
TTM4.2895Y5.474-1.185
5Y5.47410Y6.787-1.313
4.4.3.2. Quick Ratio

Measures if Scynexis is able to pay off Short-term Debt but only usingΒ theΒ most liquid assets.

  • Above 1 is considered healthy butΒ always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Quick Ratio of 8.15Β means the company can pay off $8.15 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Scynexis Inc:

  • The MRQ is 8.152. The company is very able to pay all its short-term debts with the most liquid assets. +2
  • The TTM is 6.705. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ8.152TTM6.705+1.446
TTM6.705YOY7.131-0.426
TTM6.7055Y6.442+0.263
5Y6.44210Y9.005-2.563
3rd party ad coffee SUPPORTERis ad-free.

4.5.4. Solvency of Scynexis Inc.

4.5.4. Solvency
4.5.4.1. Debt to Asset Ratio

Measures how much %Β of ScynexisΒ assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compareΒ Scynexis to Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Asset Ratio of 0.27Β means that Scynexis assets areΒ financed with 26.7% credit (debt) and the remaining percentage (100% - 26.7%)Β is financed by its owners/shareholders.Β 

Let's take a look of the Debt to Asset Ratio trends of Scynexis Inc:

  • The MRQ is 0.267. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.331. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.267TTM0.331-0.064
TTM0.331YOY0.406-0.075
TTM0.3315Y0.610-0.279
5Y0.61010Y0.552+0.058
4.5.4.2. Debt to Equity Ratio

Measures ifΒ Scynexis is able toΒ pay off its debts by usingΒ shareholders equity.

  • Below 2 is considered healthy butΒ always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A Debt to Equity ratio of 36.5% means that company has $0.36 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Scynexis Inc:

  • The MRQ is 0.365. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.512. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.365TTM0.512-0.147
TTM0.512YOY0.689-0.177
TTM0.5125Y2.839-2.327
5Y2.83910Y2.282+0.558
3rd party ad coffee SUPPORTERis ad-free.

4.6. Market Valuation

4.6.1. Earnings Per Share
4.6.2.1. Price to Earnings Ratio

MeasuresΒ how much money you payΒ for each share forΒ every $1 in earnings Scynexis generates.

  • Above 15 is considered overpriced butΒ always compareΒ Scynexis to theΒ Drug Manufacturers - Specialty & Generic industry mean.
  • A PE ratio of -1.22 means the investor is paying $-1.22Β for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Scynexis Inc:

  • The EOD is -1.987. Based on the earnings, the company is expensive. -2
  • The MRQ is -1.219. Based on the earnings, the company is expensive. -2
  • The TTM is -3.178. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-1.987MRQ-1.219-0.768
MRQ-1.219TTM-3.178+1.959
TTM-3.178YOY6.212-9.390
TTM-3.1785Y-3.210+0.032
5Y-3.21010Y-2.329-0.881
4.6.2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Scynexis Inc:

  • The EOD is -1.825. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -1.120. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is 4.924. Based on how much money comes from the company's main activities, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD-1.825MRQ-1.120-0.705
MRQ-1.120TTM4.924-6.044
TTM4.924YOY-1.986+6.910
TTM4.9245Y-5.194+10.118
5Y-5.19410Y-4.471-0.723
3rd party ad coffee SUPPORTERis ad-free.
4.6.2. Book Value per Share
4.6.2.1. Price to Book Ratio

Measures if the stock price ofΒ Scynexis is to cheap or to expensiveΒ compared to its book value.

  • At or below 1 is considered healthyΒ (always compare to Drug Manufacturers - Specialty & Generic industry mean).
  • A PB ratio of 0.76 means the investor is paying $0.76Β for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Scynexis Inc:

  • The EOD is 1.231. Based on the equity, the company is underpriced. +1
  • The MRQ is 0.755. Based on the equity, the company is cheap. +2
  • The TTM is 0.961. Based on the equity, the company is cheap. +2
Trends
Current periodCompared to+/- 
EOD1.231MRQ0.755+0.475
MRQ0.755TTM0.961-0.206
TTM0.961YOY1.305-0.344
TTM0.9615Y5.331-4.370
5Y5.33110Y4.659+0.673
4.6.2. Total Gains per Share

2.4. Latest News of Scynexis Inc

Does Scynexis Inc still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Scynexis Inc to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2025-09-04
14:30
SCYNEXIS Announces Multiple Presentations Highlighting Data from its Second-Generation Fungerp, SCY-247, at the 12th Congress on Trends in Medical Mycology (TIMM-12)Read

4.7 Holders & Insider Transactions

Let's take a look at which institutions, funds and insiders are holding shares of Scynexis Inc.

4.8.1. Institutions holding Scynexis Inc

Institutions are holding 26.578% of the shares of Scynexis Inc.

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Federated Hermes Inc7.38990.0037289500000
2025-06-30Kingdon Capital Management LLC5.71040.2033223704800
2025-06-30Vanguard Group Inc4.2290165672200
2025-06-30Avidity Partners Management LP3.1370.1652122891000
2025-03-31Acadian Asset Management LLC1.1310.00124430634430630
2025-03-31BlackRock Inc1.0780422322-3892-0.9132
2025-03-31Geode Capital Management, LLC1.07080419488144243.5609
2025-06-30Bridgeway Capital Management, LLC0.93980.0059368180146894.1554
2025-06-30AMH Equity Ltd0.66640.2315261081-365956-58.3627
2025-06-30Yakira Capital Management, Inc.0.48450.043518980200
2025-03-31Renaissance Technologies Corp0.40230.000215760085005.7009
2025-03-31Northern Trust Corp0.35130137614-15904-10.3597
2025-06-30Empowered Funds, LLC0.31130.00091219401468913.6959
2025-03-31State Street Corp0.3082012073000
2025-06-30WEALTH EFFECTS LLC0.2540.0251995001000011.1732
2025-06-30Nierenberg Investment Management Co0.19290.02717555500
2025-03-31Citadel Advisors Llc0.1847072357-25575-26.1151
2025-03-31UBS Group AG0.1758068885-15682-18.5439
2025-03-31LPL Financial Corp0.16050628805000.8015
2025-03-31Bank of New York Mellon Corp0.089503505900
Total 28.26730.707611073736+78856+0.7%

4.9.2. Funds holding Scynexis Inc

DateNameTotal SharesTotal AssetsCurrent SharesChange%
2025-06-30Federated Hermes Kaufmann Small Cap A6.20320.0503243010100
2025-06-30Federated Hermes Kaufmann Small Cap Grow6.20320.0511243010100
2025-07-31Vanguard Total Stock Mkt Idx Inv2.921201144360-25012-2.1389
2025-06-30Federated Hermes Kaufmann R1.15860.006145388700
2025-06-30Federated Hermes Kaufmann Growth1.15860.006245388700
2025-02-28Vifag 2002 SICAV0.89340.523935000000
2025-07-31Vanguard Institutional Extnd Mkt Idx Tr0.84150.0003329650-150212-31.3032
2025-06-30Fidelity Extended Market Index0.52760.0004206706-539-0.2601
2025-06-30Bridgeway Omni Small-Cap Value0.47480.011718600000
2025-06-30Bridgeway Omni Small-Cap Value N0.47480.011718600000
2025-07-31EA Bridgeway Omni Small-Cap Value ETF0.31330.005612274300
2025-06-30Extended Equity Market Fund K0.17470.000368439-1366-1.9569
2025-06-30Fidelity Total Market Index0.171206706200
2025-06-30Bridgeway Ultra-Small Company Market0.15190.03765950000
2025-06-30Fidelity Series Total Market Index0.131605156700
2025-06-30Spartan Extended Market Index Pool F0.12150.00044760100
2025-06-30NT Ext Equity Mkt Idx Fd - L0.11050.00044327100
2025-06-30Northern Trust Extended Eq Market Idx0.11050.00044327100
2025-06-30NT Ext Equity Mkt Idx Fd - NL0.09770.00043828000
2025-06-30NT Ext Equity Mkt Idx Fd - DC - NL - T20.07590.000429724-74-0.2483
Total 22.31570.70728742150-177203-2.0%

5.3. Insider Transactions

Insiders are holding 2.085% of the shares of Scynexis Inc.

DateOwnerTypeAmountPricePost Transaction AmountLink
2024-09-12Gonzalez David AnguloBUY200001.37
3rd party ad coffee SUPPORTERis ad-free.

5. Financial Statements




5.1. Latest Balance Sheet

Balance Sheet of 2025-06-30. Currency in USD. All numbers in thousands.

Summary
Total Assets60,694
Total Liabilities16,227
Total Stockholder Equity44,467
 As reported
Total Liabilities 16,227
Total Stockholder Equity+ 44,467
Total Assets = 60,694

Assets

Total Assets60,694
Total Current Assets56,498
Long-term Assets4,196
Total Current Assets
Cash And Cash Equivalents 11,020
Short-term Investments 33,765
Net Receivables 10,000
Other Current Assets 1,713
Total Current Assets  (as reported)56,498
Total Current Assets  (calculated)56,498
+/-0
Long-term Assets
Property Plant Equipment 1,934
Long Term Investments 1,736
Long-term Assets Other 526
Long-term Assets  (as reported)4,196
Long-term Assets  (calculated)4,196
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities10,863
Long-term Liabilities5,364
Total Stockholder Equity44,467
Total Current Liabilities
Short-term Debt 444
Accounts payable 6,172
Other Current Liabilities 2,477
Total Current Liabilities  (as reported)10,863
Total Current Liabilities  (calculated)9,093
+/- 1,770
Long-term Liabilities
Capital Lease Obligations 2,389
Long-term Liabilities  (as reported)5,364
Long-term Liabilities  (calculated)2,389
+/- 2,975
Total Stockholder Equity
Common Stock42
Retained Earnings -388,811
Other Stockholders Equity 433,236
Total Stockholder Equity (as reported)44,467
Total Stockholder Equity (calculated)44,467
+/-0
Other
Capital Stock42
Cash and Short Term Investments 44,785
Common Stock Shares Outstanding 49,749
Current Deferred Revenue1,770
Liabilities and Stockholders Equity 60,694
Net Debt -8,631
Net Invested Capital 44,467
Net Working Capital 45,635
Property Plant and Equipment Gross 1,934
Short Long Term Debt Total 2,389



5.2. Balance Sheets Structured

Currency in USD. All numbers in thousands.

 Trend2025-06-302025-03-312024-12-312024-09-302024-06-302024-03-312023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-312016-12-312016-09-302016-06-302016-03-312015-12-312015-09-302015-06-302015-03-312014-12-312014-09-302014-06-302014-03-312013-12-312013-09-302013-06-302013-03-312012-12-31
> Total Assets 
12,118
0
0
0
12,439
12,978
45,959
41,964
39,672
34,857
64,678
56,095
49,273
40,681
53,524
61,012
59,792
56,655
51,835
49,619
45,850
65,488
58,050
51,650
53,170
45,067
41,074
33,816
57,153
41,509
45,267
36,752
102,536
100,072
121,131
109,882
119,837
111,562
135,612
112,293
87,810
70,296
154,856
148,546
128,412
118,254
107,806
99,038
90,643
67,915
60,694
60,69467,91590,64399,038107,806118,254128,412148,546154,85670,29687,810112,293135,612111,562119,837109,882121,131100,072102,53636,75245,26741,50957,15333,81641,07445,06753,17051,65058,05065,48845,85049,61951,83556,65559,79261,01253,52440,68149,27356,09564,67834,85739,67241,96445,95912,97812,43900012,118
   > Total Current Assets 
0
2,385
0
0
3,005
2,292
40,802
36,798
34,736
29,830
64,645
55,923
48,437
39,921
52,738
54,191
59,327
55,590
50,854
48,723
44,960
64,345
56,507
50,235
51,463
40,073
36,143
28,960
52,402
36,790
40,567
32,311
98,206
95,376
115,631
103,933
109,377
101,906
125,676
103,565
79,061
59,767
145,530
128,641
102,116
101,673
94,578
80,463
72,181
52,221
56,498
56,49852,22172,18180,46394,578101,673102,116128,641145,53059,76779,061103,565125,676101,906109,377103,933115,63195,37698,20632,31140,56736,79052,40228,96036,14340,07351,46350,23556,50764,34544,96048,72350,85455,59059,32754,19152,73839,92148,43755,92364,64529,83034,73636,79840,8022,2923,005002,3850
       Cash And Cash Equivalents 
2,385
-2,385
0
0
1,454
650
38,425
34,036
32,243
27,620
57,057
53,766
46,985
38,016
37,865
29,809
35,656
19,908
7,450
8,749
11,469
27,223
6,769
16,080
11,439
12,950
19,150
11,619
41,920
20,253
34,021
29,494
93,041
92,011
112,445
100,109
104,484
95,210
118,691
68,620
45,814
26,913
57,905
44,071
34,430
35,862
25,994
28,730
16,051
6,942
11,020
11,0206,94216,05128,73025,99435,86234,43044,07157,90526,91345,81468,620118,69195,210104,484100,109112,44592,01193,04129,49434,02120,25341,92011,61919,15012,95011,43916,0806,76927,22311,4698,7497,45019,90835,65629,80937,86538,01646,98553,76657,05727,62032,24334,03638,4256501,45400-2,3852,385
       Short-term Investments 
0
4,770
0
0
0
0
0
0
0
0
0
0
0
0
12,472
22,544
22,930
34,991
41,890
38,960
32,424
36,477
48,425
33,408
32,718
26,110
16,080
16,487
6,494
14,267
3,594
0
0
0
0
0
0
0
0
27,470
27,689
27,908
27,637
44,001
40,312
44,762
47,044
40,098
43,249
33,665
33,765
33,76533,66543,24940,09847,04444,76240,31244,00127,63727,90827,68927,470000000003,59414,2676,49416,48716,08026,11032,71833,40848,42536,47732,42438,96041,89034,99122,93022,54412,4720000000000004,7700
       Net Receivables 
0
0
0
0
1,062
1,337
1,531
1,389
226
1,053
0
0
930
1,148
1,316
1,017
233
138
251
251
251
251
175
175
6,732
6,732
0
0
0
0
0
0
2,876
1,000
2,725
29
861
1,628
2,211
2,493
2,101
2,060
46,594
23,903
21,826
19,466
19,742
9,662
10,262
9,725
10,000
10,0009,72510,2629,66219,74219,46621,82623,90346,5942,0602,1012,4932,2111,628861292,7251,0002,8760000006,7326,7321751752512512512511382331,0171,3161,148930001,0532261,3891,5311,3371,0620000
       Inventory 
0
0
0
0
484
0
0
0
763
0
0
0
484
0
1,025
751
467
0
1,239
677
725
302
1,104
521
520
0
0
0
0
0
0
0
1,916
1,995
92
631
463
1,149
629
786
899
1,105
10,290
13,114
0
0
0
0
0
0
0
000000013,11410,2901,1058997866291,149463631921,9951,91600000005205211,1043027256771,23904677511,02504840007630004840000
   > Long-term Assets 
0
-2,385
0
0
9,434
10,686
5,157
5,166
4,936
5,027
33
172
836
760
786
6,821
465
1,065
981
896
890
1,143
1,543
1,415
1,707
4,994
4,931
4,856
4,751
4,719
4,700
4,441
4,330
4,696
5,500
5,949
10,460
9,656
9,936
8,728
8,749
10,529
9,326
19,905
26,296
16,581
13,228
18,575
18,462
15,694
4,196
4,19615,69418,46218,57513,22816,58126,29619,9059,32610,5298,7498,7289,9369,65610,4605,9495,5004,6964,3304,4414,7004,7194,7514,8564,9314,9941,7071,4151,5431,1438908969811,0654656,821786760836172335,0274,9365,1665,15710,6869,43400-2,3850
       Property Plant Equipment 
6,284
0
0
0
5,401
5,321
5,049
5,060
4,835
4,674
0
0
0
0
0
0
0
0
0
0
4
0
412
462
516
3,805
3,744
3,671
3,596
3,524
3,448
3,373
3,297
3,221
3,118
3,015
2,914
2,810
2,697
2,646
2,594
2,540
2,484
2,425
2,364
2,300
2,233
2,163
2,090
2,013
1,934
1,9342,0132,0902,1632,2332,3002,3642,4252,4842,5402,5942,6462,6972,8102,9143,0153,1183,2213,2973,3733,4483,5243,5963,6713,7443,8055164624120400000000004,6744,8355,0605,0495,3215,4010006,284
       Long Term Investments 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,030
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
6,336
17,115
23,594
13,943
10,657
16,116
15,846
13,155
1,736
1,73613,15515,84616,11610,65713,94323,59417,1156,336000000000000000000000000006,030000000000000000
       Intangible Assets 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
378
572
1,145
1,056
961
866
770
408
309
206
103
0
0
0
0
0
0
0
00000001032063094087708669611,0561,145572378000000000000000000000000000000000
       Long-term Assets Other 
0
-2,385
0
0
4,033
5,365
108
106
101
353
33
172
836
760
786
791
465
1,065
981
896
886
1,143
1,131
953
1,191
1,189
1,187
1,185
1,155
1,195
1,252
1,068
1,033
879
1,592
1,571
6,272
5,667
6,155
5,312
5,747
7,680
227
189
175
175
338
296
526
526
526
5265265262963381751751892277,6805,7475,3126,1555,6676,2721,5711,5928791,0331,0681,2521,1951,1551,1851,1871,1891,1919531,1311,1438868969811,065465791786760836172333531011061085,3654,03300-2,3850
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
230
107
106
104
102
100
70
110
167
277
187
187
179
206
150
0
73
73
0
73
73
0
0
0
0
0
0
0
0
000000007373073730150206179187187277167110701001021041061072300000000000000000000000
> Total Liabilities 
31,447
0
0
0
21,139
33,403
6,536
5,822
6,241
7,419
7,906
6,125
7,324
5,637
9,649
27,836
24,973
23,122
20,179
22,355
24,440
28,644
31,497
23,771
21,945
33,737
30,672
27,673
44,258
35,054
38,934
27,194
79,778
74,148
88,811
72,268
78,579
72,635
90,132
95,084
84,577
100,210
61,778
56,555
55,450
44,149
47,400
40,509
35,566
17,383
16,227
16,22717,38335,56640,50947,40044,14955,45056,55561,778100,21084,57795,08490,13272,63578,57972,26888,81174,14879,77827,19438,93435,05444,25827,67330,67233,73721,94523,77131,49728,64424,44022,35520,17923,12224,97327,8369,6495,6377,3246,1257,9067,4196,2415,8226,53633,40321,13900031,447
   > Total Current Liabilities 
14,231
0
0
0
18,477
20,513
3,781
3,197
3,801
5,132
7,051
5,393
6,664
5,041
4,523
4,038
3,717
3,358
4,673
6,675
10,144
10,852
13,154
11,086
5,877
4,638
7,248
8,092
11,014
7,054
7,316
8,305
26,396
24,932
19,879
13,220
13,616
12,944
16,012
14,264
17,618
45,644
16,158
16,790
16,303
27,349
25,233
25,719
24,099
8,957
10,863
10,8638,95724,09925,71925,23327,34916,30316,79016,15845,64417,61814,26416,01212,94413,61613,22019,87924,93226,3968,3057,3167,05411,0148,0927,2484,6385,87711,08613,15410,85210,1446,6754,6733,3583,7174,0384,5235,0416,6645,3937,0515,1323,8013,1973,78120,51318,47700014,231
       Short-term Debt 
0
0
0
0
15,000
15,000
0
0
0
0
4,243
0
0
0
0
0
14,252
14,352
1,349
2,849
4,349
3,599
5,474
7,349
0
54
56
62
72
80
86
94
104
114
120
130
140
77
199
269
282
34,944
620
650
680
12,747
13,156
13,614
14,095
850
444
44485014,09513,61413,15612,74768065062034,944282269199771401301201141049486807262565407,3495,4743,5994,3492,8491,34914,35214,252000004,243000015,00015,0000000
       Short Long Term Debt 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,252
14,352
14,452
2,849
4,349
3,599
5,474
7,349
0
27
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
34,648
0
0
0
0
12,784
13,225
13,688
0
0
0013,68813,22512,784000034,6480000000000000002707,3495,4743,5994,3492,84914,45214,35214,2520000000000000000
       Accounts payable 
1,018
0
0
0
1,932
2,660
646
640
426
1,372
477
796
619
1,380
1,136
2,468
2,192
2,044
1,738
1,832
3,833
3,331
2,590
1,975
3,653
2,346
3,806
5,825
7,177
5,222
4,853
5,254
4,639
6,516
5,946
7,510
7,848
8,130
9,960
7,419
5,937
5,925
3,416
3,490
7,149
8,918
5,350
4,955
4,569
4,260
6,172
6,1724,2604,5694,9555,3508,9187,1493,4903,4165,9255,9377,4199,9608,1307,8487,5105,9466,5164,6395,2544,8535,2227,1775,8253,8062,3463,6531,9752,5903,3313,8331,8321,7382,0442,1922,4681,1361,3806197964771,3724266406462,6601,9320001,018
       Other Current Liabilities 
1,769
0
0
0
997
1,602
2,514
2,021
3,219
3,280
6,342
4,340
5,746
3,379
3,105
1,306
1,268
1,057
1,306
1,713
1,676
3,633
4,818
1,566
2,082
2,177
3,364
2,194
3,765
1,752
2,377
2,957
21,653
18,302
13,813
5,580
5,628
4,737
5,853
6,576
11,399
4,775
8,893
10,215
7,285
4,601
5,498
5,508
3,793
2,205
2,477
2,4772,2053,7935,5085,4984,6017,28510,2158,8934,77511,3996,5765,8534,7375,6285,58013,81318,30221,6532,9572,3771,7523,7652,1943,3642,1772,0821,5664,8183,6331,6761,7131,3061,0571,2681,3063,1053,3795,7464,3406,3423,2803,2192,0212,5141,6029970001,769
   > Long-term Liabilities 
0
0
0
0
2,662
12,890
2,755
2,625
2,440
2,287
855
732
660
596
5,126
23,798
21,256
19,764
15,506
15,680
14,296
17,792
18,343
12,685
16,068
29,099
23,424
19,581
33,244
28,000
31,618
18,889
53,382
49,216
68,932
59,048
64,963
59,691
74,120
80,820
66,959
54,566
45,620
39,765
39,147
16,800
22,167
14,790
11,467
8,426
5,364
5,3648,42611,46714,79022,16716,80039,14739,76545,62054,56666,95980,82074,12059,69164,96359,04868,93249,21653,38218,88931,61828,00033,24419,58123,42429,09916,06812,68518,34317,79214,29615,68015,50619,76421,25623,7985,1265966607328552,2872,4402,6252,75512,8902,6620000
       Long term Debt Total 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
14,167
14,252
14,352
13,103
11,703
10,303
11,164
9,390
7,617
15,082
18,296
14,592
12,574
11,522
11,100
0
0
0
0
28,376
28,579
28,745
0
33,939
34,162
0
0
0
0
0
0
0
0
0
0
0
0000000000034,16233,939028,74528,57928,376000011,10011,52212,57414,59218,29615,0827,6179,39011,16410,30311,70313,10314,35214,25214,167000000000000000
       Capital Lease Obligations Min Short Term Debt
0
0
0
0
-15,000
-15,000
0
0
0
0
-4,243
0
0
0
0
0
-14,252
-14,352
-1,349
-2,849
-4,349
-3,599
-5,474
-7,349
0
3,268
3,345
3,347
3,290
3,232
3,287
3,285
3,222
3,158
3,210
3,202
3,134
3,138
3,071
2,998
2,921
-31,806
2,450
2,348
2,241
-9,904
-10,396
-10,941
-11,513
1,637
1,945
1,9451,637-11,513-10,941-10,396-9,9042,2412,3482,450-31,8062,9212,9983,0713,1383,1343,2023,2103,1583,2223,2853,2873,2323,2903,3473,3453,2680-7,349-5,474-3,599-4,349-2,849-1,349-14,352-14,25200000-4,2430000-15,000-15,0000000
       Deferred Long Term Asset Charges 
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
230
107
106
104
102
100
70
110
167
277
187
187
179
206
150
0
73
73
0
73
73
0
0
0
0
0
0
0
0
000000007373073730150206179187187277167110701001021041061072300000000000000000000000
       Warrants
0
0
0
0
0
88,790
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000000000000000000000000000000000088,79000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
0
91
8
0
0
4,594
9,164
6,601
5,078
2,154
3,792
3,872
6,571
8,953
5,068
986
29,099
23,424
19,581
33,244
28,000
31,618
18,889
53,382
49,216
838
30,469
36,218
4,102
40,181
46,658
0
54,566
44,480
0
0
0
0
0
0
0
0
0000000044,48054,566046,65840,1814,10236,21830,46983849,21653,38218,88931,61828,00033,24419,58123,42429,0999865,0688,9536,5713,8723,7922,1545,0786,6019,1644,594008910000000000
       Deferred Long Term Liability 
0
0
0
0
0
12,890
2,755
2,625
2,440
2,287
764
724
660
596
507
467
403
334
249
185
121
57
230
107
106
104
102
100
70
110
167
277
187
187
358
206
150
124
73
73
0
0
1,140
0
0
0
0
0
0
0
0
000000001,14000737312415020635818718727716711070100102104106107230571211852493344034675075966607247642,2872,4402,6252,75512,89000000
> Total Stockholder Equity
0
-19,171
0
0
-8,700
-20,425
39,423
36,142
33,431
27,438
56,772
49,970
41,949
35,044
43,875
33,176
34,819
33,533
31,656
27,264
21,410
36,844
26,553
27,879
31,225
11,330
10,402
6,143
12,895
6,455
6,333
9,558
22,758
25,924
32,320
37,614
41,258
38,927
45,480
17,209
3,233
-29,914
93,078
91,991
72,962
74,105
60,406
58,529
55,077
50,532
44,467
44,46750,53255,07758,52960,40674,10572,96291,99193,078-29,9143,23317,20945,48038,92741,25837,61432,32025,92422,7589,5586,3336,45512,8956,14310,40211,33031,22527,87926,55336,84421,41027,26431,65633,53334,81933,17643,87535,04441,94949,97056,77227,43833,43136,14239,423-20,425-8,70000-19,1710
   Common Stock
0
0
0
0
2
0
8
8
8
8
14
14
14
14
23
23
24
25
26
28
29
47
47
47
48
50
54
57
97
98
10
10
20
21
26
27
32
32
36
36
36
36
40
40
40
41
41
41
41
42
42
42424141414140404036363636323227262120101098975754504847474729282625242323141414148888020000
   Retained Earnings Total Equity00000000-333,904-456,1640-407,859-378,2750-359,479-330,236-329,631-331,289-326,613-283,902-284,811-278,430-271,428-256,970-249,029-240,626-217,718-219,660-220,011-209,252-205,250-197,660-189,260-185,059-180,123-176,674-165,446-157,318-150,134-141,746-133,392-123,895-117,511-114,436-110,632-112,86500000
   Accumulated Other Comprehensive Income 0000000000000000000000-17200-61-6100000000000000-17,608-17,285-18,447-18,335-17,977-17,66900-65,4150
   Capital Surplus 
0
0
0
0
0
3,650
150,047
150,570
150,934
151,325
190,150
191,702
192,069
192,348
209,298
209,827
214,918
218,567
220,890
224,896
226,631
246,049
246,517
247,492
248,895
251,906
259,377
263,056
284,226
284,787
291,134
293,450
349,351
357,192
361,925
367,823
400,705
0
423,719
425,032
0
426,214
426,942
0
0
0
0
0
0
0
0
00000000426,942426,2140425,032423,7190400,705367,823361,925357,192349,351293,450291,134284,787284,226263,056259,377251,906248,895247,492246,517246,049226,631224,896220,890218,567214,918209,827209,298192,348192,069191,702190,150151,325150,934150,570150,0473,65000000
   Treasury Stock000000000000000000000000000000000000000000000000000
   Other Stockholders Equity 
0
0
0
0
5,205
21,627
150,047
150,570
150,934
151,325
190,150
191,702
192,069
192,348
209,298
209,827
214,918
218,567
220,890
224,896
226,631
246,049
246,517
247,492
248,895
251,906
259,377
263,056
284,226
284,787
291,134
293,450
349,351
357,192
361,925
367,823
400,705
403,825
423,719
425,032
425,485
426,214
426,942
427,612
428,169
428,900
429,659
430,590
431,571
432,416
433,236
433,236432,416431,571430,590429,659428,900428,169427,612426,942426,214425,485425,032423,719403,825400,705367,823361,925357,192349,351293,450291,134284,787284,226263,056259,377251,906248,895247,492246,517246,049226,631224,896220,890218,567214,918209,827209,298192,348192,069191,702190,150151,325150,934150,570150,04721,6275,2050000



5.3. Balance Sheets

Currency in USD. All numbers in thousands.




5.4. Cash Flows

Currency in USD. All numbers in thousands.




5.5. Income Statements

Currency in USD. All numbers in thousands.


5.6. Latest Income Statement

Income Statement (annual), 2024-12-31. Currency in USD. All numbers in thousands.

Gross Profit (+$)
totalRevenue3,746
Cost of Revenue-0
Gross Profit3,7463,746
 
Operating Income (+$)
Gross Profit3,746
Operating Expense-40,863
Operating Income-37,117-37,117
 
Operating Expense (+$)
Research Development26,405
Selling General Administrative14,458
Selling And Marketing Expenses0
Operating Expense40,86340,863
 
Net Interest Income (+$)
Interest Income4,291
Interest Expense-2,554
Other Finance Cost-0
Net Interest Income1,737
 
Pretax Income (+$)
Operating Income-37,117
Net Interest Income1,737
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-21,137-53,097
EBIT - interestExpense = -22,863
-21,137
-18,734
Interest Expense2,554
Earnings Before Interest and Taxes (EBIT)-20,309-18,583
Earnings Before Interest and Taxes (EBITDA)-18,583
 
After tax Income (+$)
Income Before Tax-21,137
Tax Provision-151
Net Income From Continuing Ops-21,288-21,288
Net Income-21,288
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses40,863
Total Other Income/Expenses Net15,980-1,737
 

Technical Analysis of Scynexis
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Scynexis. The general trend of Scynexis is UNKNOWN with 0.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Scynexis's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator StateBullish trend Bearish trend
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Scynexis Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

SupportΒ is a price level at which demand for an asset is strong enough to prevent the price from falling further.
ResistanceΒ is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Scynexis Inc.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 1.245 < 1.41 < 1.41.

The bearish price targets are: 1.15 > 1.0999 > 1.06.

Know someone who trades $SCYX? Share this with them.πŸ‘‡

Scynexis Inc Daily Support & Resistance Chart
3rd party ad coffee SUPPORTERis ad-free.

2. Trend Indicators

2.1 Moving Averages

Shows theΒ moving averageΒ of the selected period.

  • Moving averages are laggingΒ trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Scynexis Inc. The current mas is .

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Scynexis Inc Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows theΒ momentumΒ of theΒ selected period based on two moving averages.

  • MACD is aΒ lagging momentumΒ indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Scynexis Inc.

Scynexis Inc Daily Moving Average Convergence/Divergence (MACD) ChartScynexis Inc Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Scynexis Inc. The current adx is .

Scynexis Inc Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • ShowsΒ the current trend.
  • ShowsΒ potential entry signals.
  • ShowsΒ Β potential exit signals.
  • Can be used to placeΒ trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Scynexis Inc.

Scynexis Inc Daily Parabolic SAR Chart
3rd party ad coffee SUPPORTERis ad-free.

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentumΒ indicator, meaning the signals are instant.
  • RangesΒ between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Scynexis Inc.

Scynexis Inc Daily Relative Strength Index (RSI) ChartScynexis Inc Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

ComparesΒ a certain price to multiple prices ranging over time.

  • LeadingΒ momentumΒ indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • RangesΒ between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Scynexis Inc.

Scynexis Inc Daily Stochastic Oscillator ChartScynexis Inc Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero,Β the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Scynexis Inc.

Scynexis Inc Daily Commodity Channel Index (CCI) ChartScynexis Inc Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Scynexis Inc.

Scynexis Inc Daily Chande Momentum Oscillator (CMO) ChartScynexis Inc Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

Β Shows the current price relative to the highest high over the last 14 days.
Β 

  • Lagging momentum indicator
  • Ranging between 0 andΒ -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Scynexis Inc.

Scynexis Inc Daily Williams %R ChartScynexis Inc Daily Williams %R Chart
3rd party ad coffee SUPPORTERis ad-free.

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversoldΒ 

Score

Let's take a look at the Bollinger Bands of Scynexis Inc.

Scynexis Inc Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Scynexis Inc.

Scynexis Inc Daily Average True Range (ATR) ChartScynexis Inc Daily Average True Range (ATR) Chart
3rd party ad coffee SUPPORTERis ad-free.

5. Volume Indicators

5.1 On-Balance Volume (OBV)

Β Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Scynexis Inc.

Scynexis Inc Daily On-Balance Volume (OBV) ChartScynexis Inc Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Scynexis Inc.

Scynexis Inc Daily Money Flow Index (MFI) ChartScynexis Inc Daily Money Flow Index (MFI) Chart
3rd party ad coffee SUPPORTERis ad-free.

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Scynexis Inc.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2025-04-24DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-04-25STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-05STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-05-07STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-05-09MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-12STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-14SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-05-16DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-05-19STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-20STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-05-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-05-27STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-05-28DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-05-29SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
2025-05-30MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-02STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-05STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-06STOCH SHORT EXITThe %K line crosses above the %D line.
2025-06-09STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-11STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-06-12DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-06-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2025-06-17SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-06-20STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-06-27CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-06-30STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-07STOCH LONG EXITThe %K line crosses below the %D line.
2025-07-08MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-07-10STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-14DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-07-15STOCH LONG EXITThe %K line crosses below the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2025-07-17CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-23STOCH SHORT EXITThe %K line crosses above the %D line.
2025-07-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-07-25STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-07-29DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2025-07-30SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
2025-07-31CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2025-08-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2025-08-04STOCH SHORT EXITThe %K line crosses above the %D line.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2025-08-05MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2025-08-06DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2025-08-07SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-08-08STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-11STOCH SHORT EXITThe %K line crosses above the %D line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-08-12STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-15STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-18STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-19CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2025-08-20STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-08-22STOCH LONG EXITThe %K line crosses below the %D line.
MFI SHORT ENTRY LONG CLOSE80 crossover to downside
2025-08-25STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-26STOCH LONG EXITThe %K line crosses below the %D line.
2025-08-28STOCH SHORT EXITThe %K line crosses above the %D line.
2025-08-29STOCH LONG EXITThe %K line crosses below the %D line.
2025-09-02MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
2025-09-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-05CCI LONG ENTRY SHORT CLOSE100 crossover to upside
BB SHORT ENTRY LONG CLOSEPrice closed above the lower band.
2025-09-08WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
2025-09-09MFI LONG ENTRY SHORT CLOSE80 crossover to upside
2025-09-10ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-11ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2025-09-12STOCH LONG EXITThe %K line crosses below the %D line.

6.3. Candlestick Patterns

Scynexis Inc Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Scynexis Inc based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
OpenGreater thanClose1.140
Total1/1 (100.0%)
Penke
Good job! You gained 25 XP and 0   0   10 . What's next:
  • Share my analysis of Scynexis with someone you think should read this too:
  • Are you bullish or bearish on Scynexis? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Scynexis? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Scynexis Inc

I send you an email if I find something interesting about Scynexis Inc.


Comments

How you think about this?

Leave a comment

Stay informed about Scynexis Inc.

Receive notifications about Scynexis Inc in your mailbox!

3rd party ad coffee SUPPORTERis ad-free.